The importance of positive, disruptive thinking

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Detlef Behrens, founder at Bay Pharma. A PhD pharmacist by training, Detlef is a seasoned industry professional having spent 20 years in the pharmaceutical and biotechnology space. He’s worked for several global CDMOs and now runs a biotech company. He is one of a rare breed that has seen drug development from both the CRAMS/CDMO/CMO vendor side of the fence and the sponsor side. 

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Detlef, speaking on what life is really like in a small virtual biotech company, how the pharmaceutical industry and its supply chain will evolve as a consequence of the current/ future pandemics and the role of a global one-stop shop CDMOs versus specialist companies. Detlef also explains the importance in disrupting the way we have done things in drug development in the past.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.